Retatrutide mg:15mg x 10 vials Clinically Proven PathwaysDemonstrated in trials

Clinically Proven PathwaysDemonstrated in trials to outperform GLP-1-only peptides in body weight reduction and metabolic improvement

Purity: ≥99% (HPLC Tested)

This peptide is intended strictly for laboratory

Improve insulin sensitivity

Retatrutide mg:15mg x 10 vials Clinically Proven PathwaysDemonstrated in trialsRetatrutide Peptide Triple Agonist (GLP 1 GIP Glucagon) Ultra Pure 99% for Advanced Fat Loss & Metabolic Research Welcome to the next generation of peptide science. Retatrutide is a revolutionary triple agonist targeting GLP 1, GIP, and Glucagon receptorsdelivering unmatched potential in fat loss, energy regulation, and metabolic health. Now available in ultra pure 99% pharmaceutical grade form for high performance research and experimental protocols.